NextGen sales double in 1H07, operating losses reduced

NextGen Group plc, the Cambridge-based "gene-to-protein" company, reported that sales increase increased 128% to £1.07m in the six months ended 30th June. Operating loss was lower at £1.26m, compared with £1.34m in 2006.

Chairman Anthony Rhatigan (pictutred) said the trend of increased revenues had contiued since the initial flotation of the Company in late 2005.

“From a period of uncertainty at this time last year we have seen an increasing confidence among our pharmaceutical and biotechnology clients and there have been sales of both expressionworkstation and baculoworkstation.

“In addition, the trend to outsource more parts of the drug development process by the large pharmaceutical and biotechnology companies has continued and the Company has benefitted greatly from that in both the number of clients we service and an increasing value of contracts on repeat business.

“The business of NextGen has evolved from being primarily a supplier of expert systems in the proteomics market to a company that has three distinct and growing revenue streams. These are, the original equipment business, the fee for service business and the expert IT business that has grown around the Company's novel rules engine orchestratorIMS that drives its various proteomics systems.

“NextGen continues to build its sales team in order speed up the full commercialisation of its range of products. During this period we have appointed a locally-based sales person for mainland Europe to complement the European team based in Cambridge.

“The fee-for-service business continues to show good promise for growth particularly in the US where the training of the sales team has now been completed. The team are making good progress in raising awareness of NextGen's equipment portfolio and are expecting to secure some important orders during the coming months. In addition, we have seen significant growth in the sales of the optigel range of pre-cast electrophoresis gels. During the period, we have also released an update of orchestratorIMS which has been received very favourably by existing users as well as those organisations that are considering its installation.”

28th September 2007


Previous articles
Celsis’ high margin businesses boost 1H pre-tax profits; sees further growth ahead, looks to acquisitions
Dialight signs up a major US customer for its LED White Strobe; share price on a high
ANT revenues grow, losses narrow as the way media content is viewed morphs
Domino acquires its Portuguese distributor for €7m
ARM cheers up market with record revenues, earnings in 4Q08, FY08
Prelude Trust adds 3 firms to portfolio; sees net asset value slip £0.9m
Briefs: Amino’s IPTV platform into major airline; AVEVA opens office in Brazil
University of Cambridge launches Centre for Science and Policy
Market takes dim view of Brady’s 1H07; Board confident of prospects
India's Reliance to take 74% of GeneMedix for £14.6m; will shift it to AIM
Subscribe

 

Managed Hosting by NTT Managed Hosting
SEO London by IdeaTaxi.com
Corporate profiles

 • Cambridge Consultants


Mammen Eapen
Chief Financial Officer


Cambridge Consultants has iconic status in Silicon Fen as one of the catalysts for growth of the Cambridge Cluster. For over 40 years it has helped clients turn business opportunities into commercial successes, whether launching first-to-market products, entering new markets or expanding existing markets

[Cambridge Consultants's profile]


Top20 Index




Currently: 131.89

Compare Mortgages Online
Click and compare mortgages online. It is important to consider it carefully.

marcusevans
Click to see the positive contribution of Marcus Evans to success in business.

Marcus Evans Scheme
Read about the Marcus Evans scheme and agenda for anti-corruption training.

Ferro Chrome
Would you like to know more about the ferro chrome industry. Check out the IFML website.